A daily compilation of articles, manuscripts, and news focused on the ADC market and compiled for the scientists who are making the cure everyday.
Wednesday, May 1, 2019
Bicycle Therapeutics is filing for an IPO because...
Bicycle Therapeutics is filing for an IPO because... It turns out that clinical trials are expensive. Either way, Its great to see another novel approach to ADC's (even if not technically an ADC) moving forward and having success. I'm a huge fan of novel approaches to targeted drug delivery, what do you think? https://lnkd.in/eRPVgWR ADC BicycleTherapeutics manufacturing trials
Subscribe to: Post Comments (Atom)
Post a Comment